Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular olanzapine versus intramuscular haloperidol for agitation in bipolar disorder
IRCT20230131057294N1Phase 4Completed
- Sponsor
- University of Social Welfare and Rehabilitation Sciences
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of olanzapine and haloperidol in bipolar disorder (BD) (2 arms), sponsored by University of Social Welfare and Rehabilitation Sciences. Primary endpoints: PANSS, RASS and 1 more. Started Apr 2024; status: completed.
02
Drugs
olanzapinehaloperidol
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on IRCT20230131057294N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230131057294N1.